NCT01713530 · Interventional trial
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
Overall registry status Completed
Phase 3
Conditions Diabetes, Diabetes Mellitus, Type 2
Delaware Valley sites
- Novo Nordisk Investigational Site · Lawrenceville, NJ · Mercer County
First posted
Registry updated
Added to the directory